| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2018 | Jun 22, 2018 | Brannelly Paul EVP CFO | Sell | Collegium Pharmaceutical, Inc | COLL | $27.92 | $279,165 | -7.49% |
| May 12, 2017 | May 15, 2017 | Brannelly Paul EVP CFO | Buy | Collegium Pharmaceutical, Inc | COLL | $9.18 | $91,800 | +8.32% |
| May 15, 2014 | May 15, 2014 | Brannelly Paul SVP FINANCE ADMIN TREAS | Buy | Karyopharm Therapeutics Inc. | KPTI | $25.95 | $18,165 | +1.05% |
| May 14, 2014 | May 14, 2014 | Brannelly Paul SVP FINANCE ADMIN TREAS | Buy | Karyopharm Therapeutics Inc. | KPTI | $26.93 | $21,544 | +1.21% |
| May 13, 2014 | May 13, 2014 | Brannelly Paul SVP FINANCE ADMIN TREAS | Buy | Karyopharm Therapeutics Inc. | KPTI | $28.06 | $28,057 | +1.52% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.